Mack Gene
SEC insider (Form 3/4/5 filer). CIK 0001737979. CEO, President at Gain Therapeutics, Inc. (GANX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 24, 2026. Located in BETHESDA, MD.
Companies Mack Gene has filed insider reports for
- Gain Therapeutics, Inc. (GANX): Director, Officer, CEO, President
Mack Gene
CIK: 0001737979
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GANX
Gain Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 24, 2026GANX
Gain Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
200K shares- - Mar 20, 2025GANX
Gain Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
200K shares- - Jan 6, 2025GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
271.3K shares-
1-3 of 3 transactions